Article
Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples.
Diagnostic pathology - 3 Aug 2021
Offerman Saskia, Prinsen Clemens F, Knol Ageeth, Methorst Natalie, Kamphorst Jeanette, Niemantsverdriet Maarten
Abstract excerpt
BACKGROUND: Quick and reliable testing of EGFR and KRAS is needed in non-small cell lung cancer (NSCLC) to ensure optimal decision-making for targeted therapy. The Idylla™ platform was designed for Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections but recently several studies were published that evaluated its potential for cytological specimens. This study aimed to validate the Idylla™ platform for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
